The use of antidepressant drugs in general practice K. MatthewsJ. M. EaglesC. A. Matthews Originals Pages: 205 - 210
Actual versus prescribed timing of lovastatin doses assessed by electronic compliance monitoring W. KruseT. NikolausG. Schlierf Originals Pages: 211 - 215
The effect of prostaglandin E1 during cardiopulmonary bypass on renal function after cardiac surgery K. AbeY. FujinoT. Sakakibara Originals Pages: 217 - 220
Cholic acid and ursodeoxycholic acid therapy in primary biliary cirrhosis S. GüldütunaM. LeuschnerU. Leuschner Originals Pages: 221 - 225
Trials of the bronchodilator activity of the xanthine analogue SDZ MKS 492 in healthy volunteers during a methacholine challenge test R. W. FosterA. S. JubberR. C. Small Originals Pages: 227 - 234
Amnesic effects and subjective ratings during repeated dosing of flunitrazepam to healthy volunteers J. IngumK.-M. BeylichJ. Mørland Originals Pages: 235 - 240
Acute haemodynamic effects and pharmacokinetics of ramipril in patients with heart failure B. BeermannO. NyquistM. Jensen-Urstad Originals Pages: 241 - 246
Pharmacokinetics and haemodynamic effects of a single oral dose of the novel ACE inhibitor spirapril in patients with chronic liver disease S. KrähenbühlP. GrassJ. Reichen Originals Pages: 247 - 253
The pharmacokinetic and pharmacodynamic interactions of ramipril with propranolol J. M. T. van GriensvenM. Seibert-GrafeA. F. Cohen Originals Pages: 255 - 260
Interactions of bupranolol with the polymorphic debrisoquine/sparteine monooxygenase (CYP2D6) J. PressaccoR. MullerW. Kalow Originals Pages: 261 - 264
Role of cytochrome P4502D6 in the metabolism of brofaromine N. FeifelK. KucherC. H. Gleiter Originals Pages: 265 - 269
Dextromethorphan O-demethylation polymorphism in Jordanians Y. M. IrshaidH. F. Al-HadidiN. M. Rawashdeh Originals Pages: 271 - 273
Pharmacokinetics of fenoterol in pregnant and nonpregnant women R. HildebrandtH. WeitzelU. Gundert-Remy Originals Pages: 275 - 277
Acetylator polymorphism in rheumatoid arthritis J. M. LaderoM. P. AndresJ. Benítez Short Communications Pages: 279 - 281
Changes in plasma and urinary 11-dehydrothromboxane B2 in healthy subjects produced by oral CS-518, a novel thromboxane synthase inhibitor T. UematsuW. TakasakiM. Nakashima Short Communications Pages: 283 - 286
Time course of the changes in prednisolone pharmacokinetics after co-administration or discontinuation of rifampin K. H. LeeJ. G. ShinS. G. Shin Short Communications Pages: 287 - 289
Moexipril does not alter the pharmacokinetics or pharmacodynamics of warfarin A. Van HeckenR. VerbesseltP. J. De Schepper Short Communications Pages: 291 - 293